Latest news with #AuroraCannabis
Yahoo
10-07-2025
- Business
- Yahoo
North America Legal Cannabis Market Size, Share, Trends and Forecast Report 2025-2033
North America's legal cannabis market, valued at USD 44.83 Billion in 2024, is projected to reach USD 354.82 Billion by 2033, with a CAGR of 24.55%. Growth is driven by legalization, medical applications, and product diversification. U.S. and Canada lead with expanding regulatory frameworks, while technological advances in cultivation and increasing retail and online sales support market dynamics. Major players include Canopy Growth and Aurora Cannabis. North American Legal Cannabis Market Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "North America Legal Cannabis Market Size, Share, Trends and Forecast by Products Derived, Distribution Channel, and Country, 2025-2033" has been added to offering. The North America legal cannabis market was valued at USD 44.83 Billion in 2024 and is projected to reach USD 354.82 Billion by 2033, with a compound annual growth rate of 24.55% from 2025-2033. This exponential market expansion is propelled by increasing legalization, rising medical applications, and growing consumer demand for diverse products. Advancements in regulation, investments, and technological innovations in cultivation and extraction processes are pivotal growth drivers. The U.S. and Canada are at the forefront, with state-level legalizations in the U.S. and full federal legalization in Canada fueling the market. The demand for cannabis-based pharmaceuticals is on the rise, driven by clinical research supporting therapeutic benefits for conditions like chronic pain, anxiety, and epilepsy, leading to accelerated medical adoption. A clinical trial by Johns Hopkins and Tufts University revealed that dronabinol, a synthetic cannabis pill, can reduce agitation in Alzheimer's patients by 30%, offering similar calming effects without severe side effects compared to traditional treatments. This research underscores the transformative potential of cannabis in medical treatments and is shifting public perception, leading to increased investments and product innovation. The economic advantages such as job creation and tax revenue are compelling more state governments to legalize cannabis. Product diversification is evident as edibles, beverages, and wellness products gain popularity. In September 2024, Tilray Brands unveiled plans to introduce Delta-9 THC drinks, including mocktails and seltzers, to U.S. markets, catering to diverse consumer preferences. Similarly, Seth Rogen's Houseplant launched THC-infused sparkling waters in December 2024, tapping into demand for smoke-free, low-calorie options. Technological advancements are enhancing consistency and quality in cultivation and extraction. There is a growing consumer preference for organic and sustainably sourced cannabis, prompting companies to adopt eco-friendly practices. Collaborations and investments from mainstream industries like pharmaceuticals and beverages further cement the market's growth. Key Trends: Product Diversification: The industry is experiencing significant product diversification, including edibles, cannabis-infused drinks, and topicals to cater to wellness-oriented consumers. Brands are also innovating with functional formulations combining cannabinoids with adaptogens and vitamins for stress relief, sleep, and relaxation. Rising Medical Applications: Clinical research is expanding the adoption of medical cannabis, with confirmed efficacy in managing chronic pain, epilepsy, and mental health disorders. The growing acceptance among healthcare professionals and patients is boosting demand and facilitating regulatory advancements to ensure product safety. Retail and E-Commerce Growth: The market is witnessing robust growth in retail and online sales as consumers seek convenience and access. Initiatives like DoorDash's home delivery for cannabis products respond to rising consumer demand, offering items like gummies and beverages in legally permissible states. Industry Segmentation: Analysis by product shows that marijuana remains dominant, supported by legalization and consumer demand for high-THC products. Regulated dispensaries lead in distribution channels, favored for adhering to government regulations and providing lab-tested, safe products. Competitive Landscape: The competitive landscape is characterized by product innovation, strategic partnerships, and geographic expansion. Companies focus on advanced cultivation techniques, extraction technologies, and sustainable production. Efforts to enhance testing, labeling, and consumer education underline the importance of regulatory compliance. Major Companies: 22nd Century Group, Inc. Medical Marijuana Inc. Hemp, Inc. Axim Biotechnologies, Inc. Arena Pharmaceuticals, Inc. Canopy Growth Corporation Aphria Inc. Aurora Cannabis Inc. Abcann Medicinals Inc. Key Questions Addressed: How big is the legal cannabis market in North America? What factors are driving the market growth? What is the forecast through 2033? Which segment holds the largest market share? Who are the leading market players? Key Attributes: Report Attribute Details No. of Pages 123 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $44.83 Billion Forecasted Market Value (USD) by 2033 $354.82 Billion Compound Annual Growth Rate 25.8% Regions Covered North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Legal Cannabis Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Globe and Mail
26-06-2025
- Business
- Globe and Mail
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ| TSX: ACB EDMONTON, AB, June 26, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through
Yahoo
20-06-2025
- Business
- Yahoo
Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com
Aurora Cannabis (ACB) announced that it has become aware of 'a second instance of misinformation' posted on news website On June 18, Aurora advised the market that an article posted on incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, a second article was posted on that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for distribution of medical cannabis in Germany and other EU markets. 'The company categorically denies both articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm GmbH with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions. The erroneous articles posted on state that they were generated 'with the support of AI' and reviewed by an editor. The company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that should not be considered a credible source of information regarding the company. Any information regarding material corporate transactions will be announced directly by the company to the market as soon as it is appropriate to do so,' Aurora stated. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ACB: Disclaimer & DisclosureReport an Issue Aurora Cannabis Reports Record Revenue and Growth Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics Aurora Cannabis denies acquisition of MedLeaf Therapeutics Morning Movers: Circle rises following regulatory framework for stablecoins Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Market Online
20-06-2025
- Business
- The Market Online
Cannabis Report: Clearing the air
A top Canadian global medical cannabis company has issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and strategic partnerships. Further compounding the issue, a second article incorrectly reported that it had signed a partnership to distribute medical cannabis in Germany and other European Union markets. (File image.) Click here for the full story. 1 | Aurora Cannabis files full year results and announces fiscal 2025 fourth quarter 2 | Willow Biosciences Inc. completes transformative recapitalization transactions to form Atlas Energy Corp. 3 | Apollo Capital wins proxy contest at MediPharm Labs Top Cannabis Stocks June 13 to June 19, 2025 1. | 9,388 views | Medipharm Labs Corp. 2. | 5,276 views | Canopy Growth Corp. 3. | 5,021 views | Tilray Brands Inc. 4. | 4,432 views | Curaleaf Holdings Inc. 5. | 627 views | Nextleaf Solutions Ltd. 6. | 517 views | Organigram Holdings Inc. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Globe and Mail
20-06-2025
- Business
- Globe and Mail
Aurora Cannabis Advises of Second False Article from Investing.com
NASDAQ| TSX: ACB EDMONTON, AB, June 19, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on news website,
